Journal of Obesity & Metabolic Syndrome, 30 (1), 2031
In addition, superiority was seen for death from any cause for liraglutide in LEADER (HR 0.85 [95% CI: 0.740.97]) and for the expanded composite endpoint of CV death, nonfatal MI, nonfatal stroke, revascularization, and hospitalization for unstable angina or HF with sc semaglutide in SUSTAIN 6 (HR 0.74 [95% CI: 0.620.89])
However, responsible access to these drugs is paramount, said New York-based obesity-medicine specialist Dr
CrossRef Alpha-linolenic acid regulates white adipose tissue lipolysis independent of background dietary protein Siobhan E
Giles FJ, Cortes JE, Bivins C, Andreeff M , Talpaz M, Jolivet J, Kantarjian HM